Influence of Pretransplantation Restrictive Lung Disease on Allogeneic Hematopoietic Cell Transplantation Outcomes

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 2, 2010, Pages 199-206

  Ramirez Sarmiento, Alba ^a   Orozco Levi, Mauricio ^a   Walter, Eric C ^b   Au, Margaret A ^b   Chien, Jason W ^b,c  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Allogeneic hematopoietic cell transplantation; Mortality risk; Pulmonary restriction; Survival

Indexed keywords

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; INFECTION RISK; LUNG DISEASE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; RELAPSE; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK FACTOR; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY; TREATMENT OUTCOME;

ADULT; COHORT STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LUNG DISEASES, INTERSTITIAL; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; PREVALENCE; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS AS TOPIC; TREATMENT OUTCOME;

EID: 75449115357     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.09.016     Document Type: Article

References (28)

1. Chien J.W., Madtes D.K., and Clark J.G. Pulmonary function testing prior to hematopoietic stem cell transplantation. Bone Marrow Transplant 35 (2005) 429-435
2. Ghalie R., Szidon J.P., Thompson L., et al. Evaluation of pulmonary complications after bone marrow transplantation: the role of pretransplant pulmonary function tests. Bone Marrow Transplant 10 (1992) 359-365
3. Chien J.W., Martin P.J., Gooley T.A., et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 168 (2003) 208-214
4. Chien J.W., Martin P.J., Flowers M.E., et al. Implications of early airflow decline after myeloablative allogeneic stem cell transplantation. Bone Marrow Transplant 33 (2004) 759-764
5. Horak D.A., Schmidt G.M., Zaia J.A., et al. Pretransplant pulmonary function predicts cytomegalovirus-associated interstitial pneumonia following bone marrow transplantation. Chest 102 (1992) 1484-1490
6. Ho V.T., Weller E., Lee S.J., et al. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 7 (2001) 223-229
7. Parimon T., Au D.H., Martin P.J., et al. A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med 144 (2006) 407-414
8. Parimon T., Madtes D.K., Au D.H., et al. Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation. Am J Respir Crit Care Med 172 (2005) 384-390
9. Clark J.G., Schwartz D.A., Flournoy N., et al. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med 107 (1987) 648-656
10. Crawford S.W., and Fisher L. Predictive value of pulmonary function tests before marrow transplantation. Chest 101 (1992) 1257-1264
11. Matute-Bello G., McDonald G.D., Hinds M.S., et al. Association of pulmonary function testing abnormalities and severe veno-occlusive disease of the liver after marrow transplantation. Bone Marrow Transplant 21 (1998) 1125-1130
12. Schwarer A.P., Hughes J.M., Trotman-Dickenson B., et al. A chronic pulmonary syndrome associated with graft-versus-host disease after allogeneic marrow transplantation. Transplantation 54 (1992) 1002-1008
13. Gore E.M., Lawton C.A., Ash R.C., et al. Pulmonary function changes in long-term survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys 36 (1996) 67-75
14. Goldberg S.L., Klumpp T.R., Magdalinski A.J., et al. Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem cell and bone marrow transplant recipients. J Clin Oncol 16 (1998) 3796-3802
15. Badier M., Guillot C., Delpierre S., et al. Pulmonary function changes 100 days and one year after bone marrow transplantation. Bone Marrow Transplant 12 (1993) 457-461
16. Koc S., Leisenring W., Flowers M.E., et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood 100 (2002) 48-51
17. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 854 (1995) 1-452
18. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique-1995 update. Am J Respir Crit Care Med 152 6 Pt 1 (1995) 2185-2198
19. Crapo R.O., Morris A.H., and Gardner R.M. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 123 (1981) 659-664
20. Pellegrino R., Viegi G., Brusasco V., et al. Interpretative strategies for lung function tests. Eur Respir J 26 (2005) 948-968
21. Crapo R.O., and Morris A.H. Standardized single-breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 123 (1981) 185-189
22. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 144 (1991) 1202-1218
23. Sorror M.L., Giralt S., Sandmaier B.M., et al. Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. Blood 110 (2007) 4606-4613
24. Sorror M.L., Maris M.B., Storb R., et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106 (2005) 2912-2919
25. Sorror M.L., Sandmaier B.M., Storer B.E., et al. Comorbidity- and disease status-based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation. J Clin Oncol 25 (2007) 4246-4254
26. Rochester D.F., and Esau S.A. Assessment of ventilatory function in patients with neuromuscular disease. Clin Chest Med 15 (1994) 751-763
27. Nava S. Monitoring respiratory muscles. Monaldi Arch Chest Dis 53 (1998) 640-643
28. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 166 (2002) 518-624